The Impact of Different Smoking Behavior on Pulmonary Function and Pulmonary Hypertension Among Chinese Male Patients with Chronic Obstructive Pulmonary Disease
DOI: https://doi.org/10.2147/copd.s455323
2024-06-15
International Journal of COPD
Abstract:Huina Gao, 1, * Yijun Song, 2, * Kun Liu, 1, * Xinyuan Lu, 3 Jiacheng Shen, 2 Sulan Wei, 2 Hongni Jiang, 1, 2 Nuo Xu 2 1 Department of Pulmonary Medicine, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, People's Republic of China; 2 Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China; 3 School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People's Republic of China *These authors contributed equally to this work Correspondence: Nuo Xu, Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China, Email ; Hongni Jiang, Department of Pulmonary Medicine, Xiamen Branch, Zhongshan Hospital, Fudan University, 668 Jinhu Road, Xiamen, 361015, People's Republic of China, Email Purpose: Cigarette smoking is the most recognized risk factor of chronic obstructive pulmonary disease (COPD) in China. However, there are no studies analyzing the impact of different smoking behaviors on pulmonary function and pulmonary hypertension (PH) among Chinese male patients with COPD. Patients and Methods: Chinese male smokers with COPD performed pulmonary function tests. Clinical characteristics, smoking behavior features, spirometry and echocardiographic results were compared between the two groups stratified by initial smoking age (18 years old) or complicated PH. Results: The early-smoking group had more respiratory symptoms, more severe smoking behavior, worse pulmonary function with lower FEV1%pre (38.5% vs 70.2%) and FEV1/FVC% (47.5% vs 63.8%), and higher systolic pulmonary artery pressure (sPAP: 38.6 vs 33.9 mmHg) than the late-smoking group. Initiating smoking before adulthood was an independently contributing factor of ventilatory dysfunction and Global Initiative for Obstructive Lung Disease (GOLD) stage escalation. It also had a significant interaction with long smoking duration (≥ 30 years), characterized by markedly decreased lung volumes (VC%pre: 64.0% vs 84.5%), impaired diffusing capacity (DLCO%pre: 58.0% vs 76.8%) and severe emphysema (RV/TLC%pre: 145.2% vs 130.2%). COPD patients complicated with PH exhibited worse ventilatory function (FEV1%pre: 43.2% vs 56.2%), impaired diffusion capacity (DLCO%pre: 56.7% vs 77.1%) and decreased lung volume (VC%pre: 67.67% vs 75.38%). Both severe smoking behaviors and impaired pulmonary function had close correlations with sPAP. Conclusion: The early-smoking group exhibited predominantly ventilation dysfunction and had complex interactions with long smoking duration to further affect lung volume and diffusion capacity. Different smoking behaviors influenced variations of pulmonary dysfunction and comorbid PH in patients with COPD. Keywords: chronic obstructive pulmonary disease, pulmonary function, smoking behavior, initial smoking age, pulmonary hypertension Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow obstruction and multiple comorbidities due to exposure to inhaled noxious particles, notably tobacco smoke. 1,2 According to forecasts by the World Health Organization, COPD will become one of the three leading causes of death worldwide by 2030. 3 The China Pulmonary Health study found that the direct medical cost of COPD accounted for 33.33−118.09% of the average annual income. 4 However, only 2.6% of the patients are aware of having COPD and 12% undergo pulmonary function tests. 5 The mortality rate of COPD will keep increasing unless urgent action is taken to reduce underlying risk factors, particularly tobacco use. 6 Cigarette smoking is the most recognized risk factor of COPD with an estimated 312 million Chinese who are smoking. 7 Compared to smoking-related COPD, non-smokers have predominantly small airway dysfunction with less emphysema, and slower rates of decline in ventilatory (FEV1) and diffuse function (DLCO/VA). 7,8 The pathogenesis of smoking-related COPD includes the protease, anti-protease, oxidant-antioxidant hypotheses, and abnormal repair processes. 9 The factors of smoking behavior (smoking habit, initial smoking age, smoking duration) influence the occurrence of COPD. 9 Since the decline in lung function occurs progressively after 25–35 years of age, the age factor in the case of COPD plays a critical role in increased cell aging, increased oxidative stress, and protective pathways such as autophagy. 10,11 Smoking duration and pack-years may have ne -Abstract Truncated-
respiratory system